Join
Live feed
·
PRReleasevia Quantisnow
Immunovant Inc. logo
Roivant Sciences Ltd. logo

Roivant Announces Positive Initial IMVT-1402 Phase 1 SAD and 300 mg Subcutaneous MAD Results

ByQuantisnow·Wall Street's wire, on your screen.
IMVT· Immunovant Inc.ROIV· Roivant Sciences Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IMVT (Immunovant Inc.), ROIV (Roivant Sciences Ltd.) and more on Quantisnow.